INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2001

Oral green tea extract was tolerated up to six months in cancer patients.

A phase I trial assessed the safety and pharmacokinetics of oral green tea extract in 49 adults with solid tumors over four weeks to six months. The maximum tolerated intake reached 4.2 g/m² given once per day or 1.0 g/m² taken thrice daily. Side effects were mild to moderate, primarily caffeine-related, and 10 individuals achieved stable disease.

Study type
Phase 1 clinical trial
Who was studied
49 adults with solid tumors
What was measured
Maximum-tolerated dose, toxicity, and pharmacokinetics

THE PAPER

Phase I trial of oral green tea extract in adult patients with solid tumors.

Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS. J Clin Oncol, 2001.

PubMed 11251015 ↗DOI 10.1200/JCO.2001.19.6.1830 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.